Concepedia

Raymond W. Klecker

RW

33

Publications

2.8K

Citations

24

H-Index

1981

Active since

Affiliations

National Cancer Institute(Current)

United States Food and Drug Administration

Center for Drug Evaluation and Research

National Institutes of Health

Wayne State University

Raymond W. Klecker is an author at National Cancer Institute specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

MedicinePharmacologyBiochemistryPharmacotherapyOncologyPharmacokineticsHealthRadiation OncologyBioanalysisNatural Sciences

Publications per year

1981–2013

33

Publications

33

Reversal of Adriamycin Resistance by Verapamil in Human Ovarian Cancer

Alfred M. Rogan, Thomas C. Hamilton, Robert C. Young et al. · Science · 1984 · 399 citations

Medicine, Pharmacology, Gynecology +9

Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: A Novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases

Raymond W. Klecker, Jerry M. Collins, Robert Yarchoan et al. · Clinical Pharmacology & Therapeutics · 1987 · 381 citations

Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex

Charles E. Myers, Luca Gianni, Charles B. Simone et al. · Biochemistry · 1982 · 240 citations

Engineering, Iron Metabolism, Altmetric Attention Score +22

Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans.

James L. Speyer, Paul H. Sugarbaker, Jerry M. Collins et al. · PubMed · 1981 · 220 citations

Intraperitoneal Administration, Surgical Oncology, Gastrointestinal Pharmacology +21

Clinical Pharmacokinetics of Suramin in Patients With HTLV‐III/LAV Infection

Jerry M. Collins, Raymond W. Klecker, Robert Yarchoan et al. · The Journal of Clinical Pharmacology · 1986 · 138 citations

Rows per page

1–5 of 33